Brachytherapie Literaturhinweise

 

Health technology assesment report (HTA-report) der Kassenärztlichen Bundesvereinigung und der Deutschen Bundesärztekammer zur Überprüfung evidenzbasierter behandlungsmethoden 12/2005

R. Djamali-Leonhard: Die permanente interstitielle Brachytherapie

R.Djamali-Leonhard: LDR-Brachytherapie beim lokal begrenzten Prostatakarzinom - Ein "Muss? im urologischen Armentarium
Uro-News 4/2004

P.M. Messer, E. Schneider, N.M. Blumstein, H.-W. Gottfried, Radikaloperation oder Strahlentherapie? - Stand der modernen Strahlentherapie bei der Behandlung des Prostatakarzinoms, Klinikarzt 2004; 33: 142-146.

Oheri M., Gead JR., Wheeler TM., Eastham JA., Thompson TC., Scardino PT.:
Can radical prostatectomy alter the progression of poorly differentiated prostate cancer?
J Urol 1994: 152:1843-9

Partin AW., Peund CR., Clernens JQ., Epstein JE., Walsh PC.:
Serum PSA after anatomic radical prostatectomy.
Urol Clin North Am 1993:20:713-25

Paulsen DF.:
Impact of radical prostatectomy in the management of clinically localized disease.
J Urol 1994:152:1826-30

Zincke H., Oesterling JE., Blute ML., Bergstralh EJ., Myers RP., Barrett DM.:
Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer.
J Urol 1994:152:1850-7.

Hanks GE., Lee WR., Schultheiss TE.:
Clinical and biochemical evidence of control of prostate cancer at 5 years after external beam radiation.
J Urol 1995:154:456-9

Kuban DA., EL-Mahdi AM., Schellhammer PF.
Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer.
Int J Radiat Oncol Biol Phys 1995:32:307-16

Stamey TA., Ferrari MK., Schmid HP.:
The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values characterize 80% of patients.
J Urol 1993; 150:1856-9.

Zagars GK.:
Prostate speciflc antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy.
J Urol 1994:152:1786-91

Hancock SL., Cox RS., Bagshaw MA.:
Prostate specific antigen after radiotherapy for prostate cancer: a reevaluation of Iong.term biochemical control and the kinetics of recurrence in patients treated at Standford University.
1 Urol 1995;154:1412-7

Rosenzweig KE., Morgan WR., Lytton B., Peschel RE.:
Prostate specific antigen following radiotherapy for Iocal prostate cancer.
J Urol 1995:153:1561-4

Schellhammer PF., EL-Mahdi AM., Wright GL., Kolm P, Ragle F.:
Prostate-specific antigen to determine progression-free survival after radiation therapy for Iocalized carcinoma of prostate.
Urology 1993:42:1-20

Zelefsky MJ., Wallner, KE., Ling CC., Rabe A., Hollister T., Wolfe T., Grann A., Gaudin P., Fuks Z., Leibel SA.:
Comparision of the 5-year outcome and morbidity of three-dimensional confrormal radiotherapy versus transperineal permant iodine-125 implantation for early stage prostatic cancer.
J Clin Oncol 1999:17:517-522

Slater JD., Yonemoto LT., Rossi jr CJ., Reyes-Molyneux NJ., Bush DA., Antoine JE., Loredo LN., Schulte RWM., Teichman SL., Slater JM.:
Conformal proton therapy for prostate carcinoma.
Int J Rad Oncol Biol Phys 1998:42:299-304

Ragde H., Blasko JC., Grimm PD., Kenny GM., Sylvester JE., Hoak DC., et al:
Interstitial Iodine-125 radiation witout adjuvant therapy in the treatment of clinically localized prostate carcinoma.
Cancer 1997:80:442-53

Ragde H., Elgamal AA., Snow PB., Brandt J., Bartolucci AA., Nadir BS., Korb LJ.:
Ten-Year disease free survival after transperineal sonography-guided Iodine-125 brachytherapy with or without 45-Gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason Grade prostate carcinoma.
Cancer 1998:83:989-1001

Wirth M., Alken P., Huland H.:
Interstitielle Strahlentherapie des Prostatakarzinoms.
Urologe A 1999:2:217-220

Ramos CG, Carvalhal GF, Smith DS, Mager DE, Catalona WJ:
Retrospective comparison of radical prostatectomy and 125 iodine brachytherapy for localized prostate cancer.
J Urol 1999:162:1213-1215

Stone NN, Stock RG:
Prostate brachytherapy: treatment strategies.
J Urol 1999:162:421-426

Dàmico. L Clin Oncol 200, 18:1164

Blasko. Int J Radiat Oncol Biol, 1998, 46:839

Potters l, Torre, Fearn:
Potency after permanent prostate brachytherapy for localized prostate cancer,
Int J Oncol Biol Phys 2001 Aug 1;50(5): 1235-42

M.Wirth, Th. Hermann, P.Alken, G.Kovacs, R. Müller, O.Hakenberg, L. Ahlemann, K. Schalkhäuser:
Empfehlungen zur Durchführung der alleinigen permanenten, interstitiellen Brachytherapie beim lokal begrenzten Prostatakarzinom, Strahlentherapie und Onkologie
2002-N0.2

W.Sass
Wenn Strahlen von innen heilen
Deutsches Ärzteblatt, Jg. 99, Heft 16, 19. April 2002

H. W. Gottfried, E. Schneider, P.M. Messer
Die interstitielle Brachytherapie des lokal begrenzten Prostatakarzinoms mittels permanent implantierter Strahlenquellen
Urologe B - 2- 2002

Merrick GS, Butler WM, Lief JH, Dorsey AT:
Is brachytherapy comparable with radical prostaectomy and external-beam radiation for clinically localized prostate cancer ?
Tech Urol 2001 Mar;7(1):12-9